Related Experiment Video
Updated: Aug 25, 2026

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
Published on: June 28, 2021
Leukotriene receptor antagonism in experimental acute pancreatitis in rats
Nevin Oruc1, Vahit Yukselen, A Omer Ozutemiz
1Department of Gastroenterology, Ege University Faculty of Medicine, Bornova, Izmir, Turkey.
Objectives:
Acute pancreatitis is a multifactorial disease caused by activation of several inflammatory mediators. Leukotrienes, beside other mediators, may be involved in acute pancreatitis. The aim of this study was to investigate the effects of 'zafirlukast', a leukotriene receptor antagonist, in acute pancreatitis and its relation with prostaglandin synthesis.
Methods:
Eighty rats were randomly divided into eight groups. Acute pancreatitis was induced by subcutaneous injection of cerulein (20 microg/kg), four times at 1-h intervals. Zafirlukast (20 mg/kg) was applied intraperitoneally as a pretreatment. Prostaglandin synthesis was inhibited by low-dose indomethacin (5 mg/kg subcutaneously). Pancreatic histopathology, serum amylase activity and pancreatic myeloperoxidase activity were determined to assess the severity of pancreatitis.
Results:
Zafirlukast pretreatment alone did not induce any inflammation and fatty necrosis in pancreatic tissue. However, it increased the histopathological score from 3.70 +/- 0.57 to 6.62 +/- 0.53 in rats with acute pancreatitis (P < 0.001). Fatty necrosis was especially prominent in the zafirlukast-treated acute pancreatitis group compared with the untreated group (2.62 +/- 0.26 versus 0.40 +/- 0.22, respectively; P < 0.001). Inhibition of prostaglandin synthesis by indomethacin partially suppressed the harmful effects of zafirlukast in acute pancreatitis. It decreased the pathological score (4.62 +/- 0.73) and fatty necrosis (1.50 +/- 0.32) in that group.
Conclusion:
Interestingly, leukotriene receptor antagonism by zafirlukast increased the pancreatic histopathological score and fatty necrosis in rats with acute pancreatitis. Blocking of cysteinyl leukotriene receptors might cause an induction of mediator synthesis via other pathways. Effects of leukotriene receptor antagonism on the pancreas must be evaluated extensively in further studies.
Insights
Zafirlukast, a leukotriene receptor antagonist, worsened acute pancreatitis in rats by increasing pancreatic damage. This suggests blocking leukotriene receptors may exacerbate pancreatitis through other inflammatory pathways, requiring further investigation.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Acute pancreatitis involves complex inflammatory pathways.
- Leukotrienes are implicated as potential mediators in acute pancreatitis.
Purpose of the Study:
- To investigate the effects of zafirlukast, a leukotriene receptor antagonist, on acute pancreatitis.
- To explore the relationship between zafirlukast's effects and prostaglandin synthesis in acute pancreatitis.
Main Methods:
- Acute pancreatitis was induced in rats using cerulein injections.
- Rats were pretreated with zafirlukast and/or indomethacin to inhibit prostaglandin synthesis.
- Pancreatic histopathology, serum amylase, and myeloperoxidase activity were assessed.
Main Results:
- Zafirlukast pretreatment significantly increased pancreatic histopathological scores and fatty necrosis in rats with acute pancreatitis.
- Inhibition of prostaglandin synthesis partially mitigated the adverse effects of zafirlukast.
- Zafirlukast alone did not induce pancreatic damage.
Conclusions:
- Leukotriene receptor antagonism with zafirlukast exacerbates acute pancreatitis in rats.
- Blocking cysteinyl leukotriene receptors may induce other inflammatory mediator pathways.
- Further studies are needed to fully understand leukotriene receptor antagonism's pancreatic effects.
More Related Videos
07:10Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
Published on: April 1, 2022
07:38Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
Related Concept Videos
Acute Pancreatitis II: Pathophysiology
Acute Pancreatitis I: Introduction
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis II: Pathophysiology
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...